AcouSort AB (publ) (OM: ACOU)
Health Care · Biotechnology · SE
Skr3.06
+2.00% today · +3.7% 1Y
AcouSort AB (publ) (OM: ACOU) operates in the Biotechnology industry within the Health Care sector. The company is valued at $6.54M and employs 11 people.
Over the last twelve months the share price has gained 3.7%, trading between 2.03 and 5.16.
Tweenvest scores AcouSort AB (publ) across four factors: quality 37/100, value 51/100, growth 71/100. Its strongest factor is growth.
ACOU price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $6.54M
- Revenue (TTM)
- $961.00K
- P/E
- —
- EPS
- -0.53
- Dividend yield
- —
- Beta (5Y)
- 0.13
- 52-week high
- Skr5.16
- 52-week low
- Skr2.03
- Avg volume (3M)
- —
- Shares outstanding
- 21.16M
- Employees
- 11
- Next earnings
- —
About AcouSort AB (publ)
AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy and other elements of the future automated systems. AcouSort AB (publ) was founded in 2010 and is based in Lund, Sweden.
- ISIN
- SE0009189608
- Founded
- 2010
- Listed since
- Dec 14, 2020
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| FibroBiologics, Inc.NasdaqCM: FBLG | $6.75M | $0.97 | -14.07% |
| Alaunos Therapeutics, Inc.NasdaqCM: TCRT | $6.68M | $2.63 | +234.69% |
| Arctic Bioscience ASOB: ABS | $6.59M | Nkr2.31 | -12.50% |
| VitaSpring Biomedical Co. Ltd.OTCPK: VSBC | $6.58M | $0.03 | — |
| Curative Biotechnology, Inc.OTCPK: CUBT | $6.50M | $0.91 | -4.27% |
| Subgen AI AB (publ)OM: SUBGEN | $6.44M | Skr0.03 | +7.33% |
| XTL Biopharmaceuticals Ltd.TASE: XTLB | $6.41M | ₪0.02 | -6.25% |
| Theracryf PlcAIM: TCF | $6.38M | £0.00 | +2.94% |
Figures last refreshed Oct 18, 2026.